For ALK+ ALCL, the presence of the NPM‐ALK fusion gene has been described to positively regulate the movement of the cells by phosphorylation of VAV1 and VAV3 and consequent activation of RAC1.32, 33. The gene discussed is VAV3; the disease is anaplastic large cell lymphoma.